‘A new shareholder for Prevent Vaccins’:
After four intense years of collaboration, we have successfully sold our shares in Prevent Vaccins to European Life Care Group, backed by Inflexion. Navigating through the challenges of the COVID-19 pandemic, we experienced both highs and lows together. Despite the significant disruptions caused by the pandemic, including severely limited international travel, we managed to keep the company stable..